Differential serum proteome profiling and electrochemical biosensing of leucine-rich alpha-2-glycoprotein (LRG1) and lipopolysaccharide-binding protein (LBP) as subtype-specific biomarkers for HPV-negative cervical cancer

Background Cervical cancer (CC) is still a major global health concern. Specifically, human papillomavirus (HPV) - negative CC (HPV-neg CC) has a poorer prognosis than HPV-positive cases (HPV-pos CC). Distinguishing between HPV-pos and HPV-neg CC is the focus of this study, using proteomics and electrochemical biosensors. Methods Pooled serum samples from healthy individuals, HPV-pos CC, and HPV-neg CC patients were analyzed using label-free quantitative proteomics. Differentially expressed proteins (DEPs) were analyzed using PEAKS ® Studio software (≤1% False Discovery Rate, FDR; 1.5-fold change threshold). STRING and Metascape databases were used for protein-protein interaction analysis and functional clustering. An electrochemical impedance spectroscopy (EIS) biosensor was developed to quantify potential candidate biomarkers including lipopolysaccharide-binding protein (LBP) and leucine-rich alpha-2-glycoprotein (LRG1). Results Proteomics revealed distinct signatures, associating HPV-pos and HPV-neg CC with humoral immune response impairment and systemic inflammatory response, respectively. Concurrently, inflammatory mediators, LBP and LRG1 were top DEPs across all groups, with 3.99 and 2.89-fold increases in HPV-neg CC vs. healthy control, respectively. The EIS-based biosensor verified that LBP had remarkable discriminatory power in separating HPV-pos CC cases from HPV-neg CC cases (AUC = 0.9815), whereas LRG1 successfully separated cancer cases from healthy controls (AUC = 1.000). Conclusions Proteomics and EIS biosensor techniques identified LBP as a potential biomarker linked to systemic inflammatory responses in HPV-neg CC. Therefore, this pilot study links the gap between proteomic discovery and clinical application, eventually providing exploratory insights into subtype characterization for HPV-neg CC. Further investigations in a larger cohort based on our findings are necessary for a better understanding of the role of LBP and LRG1 in all CC subtypes.

Authors

Institutions

Publication Details

Journal
PeerJ
Published
2026-11-18
DOI
https://doi.org/10.7717/peerj.21759
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Differential serum proteome profiling and electrochemical biosensing of leucine-rich alpha-2-glycoprotein (LRG1) and lipopolysaccharide-binding protein (LBP) as subtype-specific biomarkers for HPV-negative cervical cancer

Juthamard Chantaraamporn, Churat Weeraphan, Theetat Ruangjaroon, Jisnuson Svasti et al.
3 links
PeerJ
Cervical Cancer and HPV Research
article

Differential serum proteome profiling and electrochemical biosensing of leucine-rich alpha-2-glycoprotein (LRG1) and lipopolysaccharide-binding protein (LBP) as subtype-specific biomarkers for HPV-negative cervical cancer

Juthamard Chantaraamporn, Churat Weeraphan, Theetat Ruangjaroon, Jisnuson Svasti, Chantragan Srisomsap, Penchatr Diskul‐Na‐Ayudthaya, Daranee Chokchaichamnankit, Narongrit Sritana, Kamolwan Watcharatanyatip, Nuttavut Kantathavorn, Amita Mekarunothai
article en

Abstract

Background Cervical cancer (CC) is still a major global health concern. Specifically, human papillomavirus (HPV) - negative CC (HPV-neg CC) has a poorer prognosis than HPV-positive cases (HPV-pos CC). Distinguishing between HPV-pos and HPV-neg CC is the focus of this study, using proteomics and electrochemical biosensors. Methods Pooled serum samples from healthy individuals, HPV-pos CC, and HPV-neg CC patients were analyzed using label-free quantitative proteomics. Differentially expressed proteins (DEPs) were analyzed using PEAKS ® Studio software (≤1% False Discovery Rate, FDR; 1.5-fold change threshold). STRING and Metascape databases were used for protein-protein interaction analysis and functional clustering. An electrochemical impedance spectroscopy (EIS) biosensor was developed to quantify potential candidate biomarkers including lipopolysaccharide-binding protein (LBP) and leucine-rich alpha-2-glycoprotein (LRG1). Results Proteomics revealed distinct signatures, associating HPV-pos and HPV-neg CC with humoral immune response impairment and systemic inflammatory response, respectively. Concurrently, inflammatory mediators, LBP and LRG1 were top DEPs across all groups, with 3.99 and 2.89-fold increases in HPV-neg CC vs. healthy control, respectively. The EIS-based biosensor verified that LBP had remarkable discriminatory power in separating HPV-pos CC cases from HPV-neg CC cases (AUC = 0.9815), whereas LRG1 successfully separated cancer cases from healthy controls (AUC = 1.000). Conclusions Proteomics and EIS biosensor techniques identified LBP as a potential biomarker linked to systemic inflammatory responses in HPV-neg CC. Therefore, this pilot study links the gap between proteomic discovery and clinical application, eventually providing exploratory insights into subtype characterization for HPV-neg CC. Further investigations in a larger cohort based on our findings are necessary for a better understanding of the role of LBP and LRG1 in all CC subtypes.

PeerJVol. 14
Chulabhorn Graduate Institute (TH), Chulabhorn Research Institute (TH), Chulabhorn Hospital (TH), Chulabhorn Royal Academy (TH), HRH Princess Chulabhorn College of Medical Science (TH)
Chulabhorn Research Institute, Thailand Science Research and Innovation
Good health and well-being
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon